PET Imaging
Image-Guided Surveillance Beneficial for Head and Neck Cancer
March 29, 2016Similar survival seen for PET-CT-guided surveillance and planned neck dissection, but fewer operations.
PET Imaging Promising for Metastatic Prostate Cancer
February 12, 2016Positron emission tomography (PET) imaging may offer a superior method of imaging for metastatic prostate cancer.
PET Can Guide Subsequent Treatment in Advanced Stage Hodgkin Lymphoma
December 08, 2015PET deemed safe for use after two cycles of BEACOPPesc chemotherapy for advanced stage Hodgkin lymphoma, according to a recent study.
PET scan use for NSCLC varies by demographic subgroup
June 10, 2013From 1998 to 2007, more PET scans for married, non-black, <80-year-old patients with lung cancer were performed.
21st Century Breast Imaging
July 11, 2012Advances in imaging for breast cancer screening, diagnosis, and response assessment are more promising now than ever before.
PET more sensitive than CT for Merkel cell carcinoma
May 16, 2012F-18-FDG PET more sensitive, equally specific to CT for assessing regional lymph node involvement.
PET imaging may help predict survival in cancer patients
April 05, 2010Doctors may be able to use pretreatment PET imaging to better fight aggressive cancers, according to a study presented at the 2010 Multidisciplinary Head and Neck Cancer Symposium in Chandler, Arizona.
Sign Up for Free e-newsletters
ONA Articles
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |